Circio selected for oral presentation at prestigious ASGCT annual meeting

Summary by AI BETAClose X

Circio Holding ASA has been selected for an oral presentation at the prestigious American Society of Gene and Cell Therapy annual meeting in Boston from May 11-15, 2026, with abstracts to be published on April 13, 2026. The company submitted two abstracts, one for oral and one for poster presentation, highlighting its circVec technology which has demonstrated up to a 75-fold increase in RNA half-life and a 40-fold enhancement in protein expression compared to conventional mRNA systems. This presentation offers a significant opportunity to showcase their technology to industry professionals and explore potential partnerships.

Disclaimer*

UK 100

Latest directors dealings